Pure Global

PKL BILIRRUBINA DIRECTA - COFEPRIS Registration 99R2022 SSA

Access comprehensive regulatory information for PKL BILIRRUBINA DIRECTA (PKL DIRECT BILIRUBIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 99R2022 SSA and manufactured by AXMILAB, S.A. DE C.V.. The device was registered on November 02, 2022.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
99R2022 SSA
PKL BILIRRUBINA DIRECTA
COFEPRIS Analysis ID: 99R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

PRUEBAPARALADETERMINACIร“NCUANTITATIVAINVITRODE BILIRRUBINA DIRECTA EN SUERO O PLASMA HUMANO.

English

TEST FOR THE QUANTITATIVE DETERMINATION INVITRODE DIRECT BILIRUBIN IN HUMAN SERUM OR PLASMA.

Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. AGENTES DE DIAGNร“STICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
PRUEBA PARA DETERMINARBILIRRUBINA
Trade Name (English)
BILIRUBIN TEST
Registration Information
Analysis ID
99R2022 SSA
Registration Date
November 02, 2022
Manufacturer / Fabricante
Name (Spanish)
AXMILAB, S.A. DE C.V.
Name (English)
AXMILAB, S.A. DE C.V.